Clinical Trial Update: Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating darbepoetin alfa for anemia in cancer patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Cancer

Drugs mentioned

• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Amgen | Conditions: Anemia, Cancer | Phase 3 | Status: COMPLETED